CRA is a proud sponsor of this event.
Ashley Fraser is moderating a panel that will discuss how to “Prepare your Organization for Changes to Canada’s Drug Procurement Strategy.”
For more information on this event, click here.
ASCO 2024 review: The benefits and barriers of biomarkers in oncology
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...